Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

REMEVi vs Revel Health

REMEVi
Graded #70

Higher grade

vs+7.299999999999997
Revel Health
Graded #197

Lower grade

The verdict

REMEVi takes it — 73.5/100 to 66.2/100.

REMEVi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRevel Health +3
57
60
Dose & formulationREMEVi +19
83
64
Clinical oversightREMEVi +4
86
82
Labs & monitoringREMEVi +3
55
52
FulfillmentREMEVi +15
97
82
Contract termsREMEVi +14
69
55
REMEVi · left barRevel Health · right bar

The numbers

MetricREMEViRevel Health
WeighScore73.5/10066.2/100
GradeCC
Scorecard rank#70#197
Semaglutide$219/mo$199/mo (compounded)
Tirzepatide$319/mo$249/mo (starting dose, compounded)
CoverageAll 50 states45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
REMEVi

Graded #70 · C

Strengths

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
  • A daily oral semaglutide tablet is offered alongside the injection
  • Available in all 50 states and DC, with no minimum commitment and no cancellation fee

Where it loses points

  • The flat rate is the highest entry price of the top-scoring programmes here; the cheaper $149 figure needs a full year
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Revel Health

Graded #197 · C

Strengths

  • LegitScript certified with board-certified physicians and USP 795/800 compounding
  • Combines GLP-1 weight loss with NAD+, sermorelin and longevity care
  • Fast intake — a physician reviews within the hour
  • Available in 45 states with a clear list of where it operates

Where it loses points

  • Doesn't show upfront pricing — you learn cost during checkout
  • Not available in AK, AR, NC, NJ or MS
  • Compounded medications only — no brand-name options noted
  • Longevity add-ons add cost beyond the core GLP-1 program

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard